NCT05707286View on ClinicalTrials.gov

Pilot Study to Determine Pro-Inflammatory Cytokine Kinetics During Immune Checkpoint Inhibitor Therapy

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

September 7, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions

MelanomaGastrointestinal NeoplasmsGenitourinary CancerThoracic CancerSarcoma

Trial Locations (1)

46202

Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis

All Listed Sponsors

collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

lead

Indiana University

OTHER

NCT05707286 - Pilot Study to Determine Pro-Inflammatory Cytokine Kinetics During Immune Checkpoint Inhibitor Therapy | Biotech Hunter | Biotech Hunter